• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down2.84% Nasdaq Down2.94%

    Dicerna Pharmaceuticals, Inc. (DRNA)

    -NasdaqGS
    10.60 Down 0.37(3.37%) Sep 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   7,015  
    Cost of Revenue -   -   -  
    Gross Profit -   -   7,015  
    Operating Expenses
    Research Development29,453  11,558  11,565  
    Selling General and Administrative15,648  5,820  4,700  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (45,101) (17,378) (9,250)
    Income from Continuing Operations
    Total Other Income/Expenses Net(2,639)(188)471  
    Earnings Before Interest And Taxes(47,597)(17,248)(8,779)
    Interest Expense199  952  1,342  
    Income Before Tax(47,796)(18,200)(10,121)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(47,939)(18,518)(10,121)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (47,939) (18,518) (10,121)
    Preferred Stock And Other Adjustments(204)(2,388)(4,097)
    Net Income Applicable To Common Shares (48,143) (20,906) (14,218)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.